Healthcare Services

Sanger Sequencing Market 2025-2034: Key Highlights, Growth Dynamics, and Emerging Trends

2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!

Which Major Market Drivers Are Expected to Boost the Growth Potential of the Sanger Sequencing Market?

The increasing incidence of genetic disorders is anticipated to fuel the expansion of the sanger sequencing market in the future. Genetic disorders are medical conditions resulting from abnormalities in a person’s DNA, the inherited material carrying genetic information. Sanger sequencing, which determines the precise sequence of nucleotides (the DNA’s basic units) in a specific gene or DNA region, is utilized to identify these genetic diseases. For example, the National Health Service, a publicly funded healthcare system in the UK, reported in August 2024 that around 2,300 UK residents are suffering from thalassaemia. Of these, approximately 800 suffer from a severe form of the disease and require regular blood transfusions. Thus, the proliferation of genetic diseases is stimulating the growth of the sanger sequencing market.

Get Your Free Sample Report Now – Explore Exclusive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=13925&type=smp

#What is the Anticipated CAGR of the Sanger Sequencing Market, and What Factors Will Drive It?

The market size for sanger sequencing has seen quick expansion in the last few years. Its growth is projected to escalate from $2.75 billion in 2024 to $3.3 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 19.8%. The surge during the previous period can be linked to a rise in research requirements, an upsurge in medical diagnostics, amplified pharmaceutical innovations, a growth in agricultural uses, an escalation in forensic analysis, improved biomarker discovery, and an increase in the study of genetic evolution.

Anticipations indicate an accelerated growth trajectory for the Sanger sequencing market in the upcoming years. By 2029, the market is estimated to reach $6.17 billion, growing at a Compound Annual Growth Rate (CAGR) of 16.9%. This projected expansion during the forecast period is correlated with factors such as more integration of clinical genomics, growth in agricultural genomics, enhancements in drug safety and pharmacogenomics, a surge in prenatal and newborn screening, along with the rising trend in environmental DNA analysis. Key trends throughout the forecast period encompass technology advancements, escalated demand for next-generation sequencing, more applications in clinical diagnostics, increased funding in genomics research, and a broader utilization in the domain of personalized medicine.

You can Directly Purchase the Report Here:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=13925

What Are the Key Market Innovations in theSanger Sequencing Market Over the Coming Years?

Primary businesses in the Sanger sequencing market are putting their efforts into broadening genomic labs in order to accelerate their Sanger sequencing services across the upper regions of the UK. Genomic labs, known for conducting genetic examinations and analyses, are centres for studying genetic structure, functionality, and inheritance, often for diagnostic purposes, research, and personalized medicine. For example, in June 2023, Source Genomics, a company based in the UK that provides genomic services, announced plans to expand their genomic lab into the north of the UK. This will enhance the efficiency of their Sanger sequencing services and fast-track the data delivery process. This expansion to the north is a significant step towards ensuring nationwide access to top-notch genomic services for research institutions. This geographical expansion will allow clients all over the country to experience high-quality Sanger sequencing services with rapid turnaround times.

Who Are the Top Companies Driving Innovation and Growth in theSanger Sequencing Market?

Major companies operating in the sanger sequencing market report are Hoffmann-La Roche, Thermo Fisher Scientific Inc., Merck KGaA, Eurofins Scientific, Illumina Inc., Beckman Coulter, PerkinElmer Inc., BGI Group, LGC Limited, GenScript, Oxford Nanopore Technologies, Pacific Biosciences of California Inc., Macrogen Inc., GENEWIZ Inc., Quintara Biosciences, CeMIA SA, Source BioScience, Microsynth AG, Fasteris SA, GenHunter Corporation, Nucleics Pty. Ltd., SciGenom Labs Pvt. Ltd., StarSEQ GmbH, GATC Biotech AG, Agilent Technologies

Order Your Report Now For A Swift Delivery:

https://www.thebusinessresearchcompany.com/report/sanger-sequencing-global-market-report

Which Key Market Segments Comprise the Sanger Sequencing Market and Drive Its Revenue Growth?

The sanger sequencing market covered in this report is segmented –

1) By Sequencing: Shotgun Sequencing, Targeted Gene Sequencing, Other Sequencing

2) By Laboratory: Wet Labs, Dry Labs

3) By Research: In-House, Outsourced

4) By Application: Diagnostics, Biomarkers and Cancer, Reproductive Health, Personalized Medicine, Forensics, Other Applications

5) By End User: Academic, Government Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Hospitals, Clinics

Subsegments:

1) By Shotgun Sequencing: Whole Genome Shotgun Sequencing, Metagenomic Shotgun Sequencing

2) By Targeted Gene Sequencing: Amplicon Sequencing, Exome Sequencing

3) By Other Sequencing: Nested PCR Sequencing, Sequencing By Synthesis (SBS)

Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!

https://www.thebusinessresearchcompany.com/customise?id=13925&type=smp

Which Regions Are Emerging as Leaders in the Sanger Sequencing Market?

North America was the largest region in the sanger sequencing market in 2024. The regions covered in the sanger sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Browse Through More Reports Similar to the Global Sanger Sequencing Market 2025, By The Business Research Company:

Clinical Oncology Next Generation Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/clinical-oncology-next-generation-sequencing-global-market-report

Whole Exome Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report

Short Read Sequencing Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/short-read-sequencing-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *